Compare international online pharmacies prices and services

Product Name: Nilotinib
Generic Name: Nilotinib
Common Brands: Tasigna
Pharmaceutical Categories: Cancer

Where to buy Nilotinib online:

Shop | Product | Forms | Strength | Conditions
  • Tasigna capsules 200 mg
  • 5% discount coupon: 5OFF
  • Payment: Visa, Mastercard, AmEx, Bitcoin
  • Shipping: worldwide
  • Delivery: unregistered mail, trackable courier

  • Nilotinib (trade names include Tasigna, Tasinga, Nilotib) is an anti cancer medication from protein kinase inhibitors pharmacological group. This medicine is used for the treatment of Philadelphia chromosome (Ph+)-positive chronic myelogenous leukaemia. It is also in research phases for the therapy of Parkinson's disease, Alzheimer's disease, Amyotrophic lateral sclerosis, dementia, Huntington's disease, gastrointestinal stromal tumor. It works by inhibiting various enzymes called kinases.

    Tasigna (Nilotinib) capsules 200 mg

    Customers also buy these medications from the same pharmacological classes:

  • Abemaciclib (Verzenio, Verzenios)
  • Abiraterone (Zytiga)
  • Anastrozole (Arimidex)
  • Axitinib (Inlyta)
  • Bosutinib (Bosulif)
  • Brigatinib (Alunbrig)
  • Encorafenib (Braftovi)
  • Exemestane (Exemestan)
  • Gefitinib (Iressa)
  • Ibrutinib (Imbruvica)
  • Imatinib (Gleevec)
  • Larotrectinib (Vitrakvi)
  • Letrozole (Femara)
  • Melphalan (Alkeran)
  • Nintedanib (Ofev, Vargatef)
  • Olmutinib (Olita)
  • Pazopanib (Votrient)
  • Ponatinib (Iclusig)
  • Regorafenib (Stivarga)
  • Ribociclib (Kisqali)
  • Rociletinib (Xegafri)
  • Sorafenib (Nexavar)
  • Tivozanib (Fotivda)

    Pharmaceutical and medical classifications:

  • Anti cancer drugs
  • Antineoplastic medicines
  • Oncological treatment
  • Leukaemia therapy

    The Anatomical Therapeutic Chemical (ATC) classification system (developed by the World Health Organization):

  • L - Antineoplastic and immunomodulating agents
  • L01 - Antineoplastic agents
  • L01X - Other antineoplastic agents
  • L01XE - Protein kinase inhibitors
  • L01XE08 - Nilotinib

    Medical conditions for estrogens conjugated in the International Statistical Classification of Diseases and Related Health Problems:

  • Malignant neoplasm of other connective and soft tissue - C49
  • Gastrointestinal stromal tumor, unspecified site - C49.A0
  • Myeloid leukemia - C92
  • Mental disorders due to known physiological conditions - F01-F09
  • Huntington's disease - G10
  • Spinal muscular atrophy and related syndromes - G12
  • Amyotrophic lateral sclerosis - G12.21
  • Parkinson's disease - G20
  • Alzheimer's disease - G30

    Pregnancy category:

  • D - Australia
  • D - United States (Positive evidence of risk)

    Forms of active pharmaceutical ingredients (APIs):

  • Nilotinib Base
  • Nilotinib Hydrochloride
  • Nilotinib Hydrochloride Dihydrate
  • Nilotinib Hydrochloride Monohydrate

    Chemical, international, and other names of this drug:

  • AMN107
  • Nilotinib HCl
  • Nilotinibe
  • Nilotinibi
  • Nilotinibum
  • Nilotynib

    Most known trade names (brands and generics) worldwide:

  • Tasigna - Novartis
  • Tasinga - Novartis
  • Nilotib - Caprane Pharmaceutical
  • Nilotinib - Actiza Pharmaceutical

    References and external sources:

  • Nilotinib main article on Wikipedia:
  • Nilotinib compound on PubChem:
  • Nilotinib Hydrochloride compound on PubChem:
  • Nilotinib Hydrochloride Monohydrate compound on PubChem:
  • Nilotinib Hydrochloride Dihydrate compound on PubChem:
  • Nilotinib medicine on DrugBank:
  • Nilotinib Hydrochloride Monohydrate on DrugBank:
  • Nilotinib FAQ on MedlinePlus (revised 12/15/2021):
  • Nilotinib information on the U.S. National Cancer Institute (revised December 30, 2020):
  • Tasigna (Nilotinib) capsules drug label on DailyMed (revised February 15, 2022):
  • Tasigna (Nilotinib) 150 mg, 200 mg capsules official website for U.S. residents only:
  • Tasigna (Nilotinib) official website for non-U.S. residents powered by Novartis:
  • Tasigna (Nilotinib) capsules official prescribing information and medication guide from the U.S. FDA (revised 12/2020):
  • Tasigna (Nilotinib) capsules for oral use prescribing information and medication guide on Novartis pharmaceutical company website (revised 09/2021):
  • Tasigna (Nilotinib) 150 mg hard capsules patient information leaflet on (revised November 2020):
  • Tasigna (Nilotinib) 200 mg hard capsules patient information leaflet on (revised November 2020):

    Revised: April 2022

  • Disclaimer: Please note, this website is not an online pharmacy, drugstore and related online pharma shop. It does not sell, supply or advertise any prescription and OTC drugs, medications, other goods and services. All reviews, links, lists, databases, texts, and other content on the website are provided free and only for informational and educational purposes. Medical content on this website, including drug names, indications, contraindication, side effects, categories, classifications, forms, doses, prices, other health and pharmaceutical information are taken only from trusted and authoritative professional sources (see "References"), reviewed and prepared by our licensed experts, content inspectors and editors.
    You should always consult your doctor or other healthcare professional before using any medication. This website, our staff and support do not provide own medical instructions and advices.
    All brands and trade names appearing on the website are registered trademarks and intellectual property of their respective companies.
    Remember that buying drugs and medicines online is a responsibility only of customers, sellers and suppliers regarding existing legislation in their jurisdictions.

    Share us in social media:

    Home | Sitemap | Privacy Policy | Cookies Policy | Terms of Service | References | Contact Us

    Copyright © 2007 - 2022 All rights reserved.